STACY HERNANDEZ: Open Payments
NPI 1215434253 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,387 in 114 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $4,399 · 2025 $3,387
Food & beverage: $3,221Education: $166
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $550 |
| GENZYME CORPORATION | 10 | $504 |
| ABBVIE INC. | 21 | $479 |
| Janssen Biotech, Inc. | 14 | $451 |
| Lilly USA, LLC | 8 | $203 |
| Novartis Pharmaceuticals Corporation | 11 | $163 |
| Regeneron Healthcare Solutions, Inc. | 7 | $154 |
| Organon LLC | 4 | $143 |
| Neurelis, Inc. | 1 | $122 |
| ACADIA Pharmaceuticals Inc | 2 | $114 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, RINVOQ, SKYRIZI, EBGLYSS, VTAMA, VALTOCO.
Industry payments across VA — which companies pay providers there.
